Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/1995
10/26/1995CA2187771A1 Rps gene family, primers, probes, and detection methods
10/26/1995CA2187670A1 Method for the immuno-assay of antithrombin iii activated by a glycosaminoglycan, corresponding monoclonal antibodies and method for producing them
10/26/1995CA2186639A1 Cell-cycle regulatory proteins, and uses related thereto
10/25/1995EP0678744A2 Method for detecting urinary tumor associated antigens
10/25/1995EP0678524A1 Anti-human soluble fibrin antibody hybridoma, and immunoassaying method
10/25/1995EP0678523A1 Recombinant anti-hiv antibody and preparation thereof
10/25/1995EP0678122A1 Recombinant anti-vla4 antibody molecules
10/25/1995EP0678101A1 Growth differentiation factor-9
10/25/1995EP0678031A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
10/25/1995EP0678028A1 Dna encoding a human betaine/gaba transporter and uses thereof
10/25/1995EP0506818B1 Method of covalently bonding proteins to hydrophilic surfaces
10/25/1995EP0433378B1 ALLELIC VARIANTS OF $i(PLASMODIUM FALCIPARUM) MEROZOITE SURFACE ANTIGEN
10/25/1995EP0294392B1 Diagnostic and therapeutic antibody conjugates
10/24/1995US5460978 Protein active in humoral hypercalcemia of malignancy-PthrP
10/24/1995US5460976 Detection of reproductive hormone levels in equines
10/24/1995US5460963 Plants transformed with a DNA sequence from Bacillus thuringiensis lethal to Lepidoptera
10/24/1995US5460960 Isolating antibodies produced by a hapten similar to both the reactant and catalyst; modifying these antibodies by binding a converting hapten for the reactant/actual catalyst complex
10/24/1995US5460951 Bone-related carboxypeptidase-like protein and process for its production
10/24/1995US5460947 Apolipoprotein B-specific monoclonal antibodies produced by two novel hybridomas
10/24/1995US5460801 Inhibition of small cell lung cancer cell growth in vivo using monoclonal antibody
10/24/1995US5460785 Direct labeling of antibodies and other protein with metal ions
10/24/1995CA1337403C Methods for the production of antibodies and induction of immune responses to tumor-associated gangliosides by immunization with ganglioside lactones
10/19/1995WO1995027793A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICErel-II)
10/19/1995WO1995027792A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICErel-III)
10/19/1995WO1995027784A1 Cisplatin resistance gene and uses therefor
10/19/1995WO1995027781A1 Superoxide dismutase-4
10/19/1995WO1995027736A1 Use of agents which block intercellular adhesion molecule/receptor interaction in the treatment of respiratory viral infection
10/19/1995WO1995027735A1 Apoptose inhibitor
10/19/1995WO1995027732A2 Circularly permuted ligands and circularly permuted chimeric molecules
10/19/1995WO1995027509A1 Remedy for diseases characterized by abnormal accumulation or activation of leukocyte
10/19/1995WO1995024481A3 Humanized monoclonal antibodies against human interleukin-4
10/19/1995WO1995020658A3 Diagnosis and treatment of infections due to streptococci and enterococci
10/19/1995CA2187635A1 Superoxide dismutase-4
10/19/1995CA2187360A1 Use of agents which block intercellular adhesion molecule/receptor interaction in the treatment of respiratory viral infection
10/19/1995CA2164723A1 Remedy for diseases characterized by abnormal accumulation or activation of leukocyte
10/19/1995CA2163526A1 Cisplatin resistance gene and uses therefor
10/18/1995EP0677533A2 Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof
10/18/1995EP0677532A1 Use of Il-1-antagonists as medicaments for treating diseases with increased Interleukin-6 serum levels
10/18/1995EP0677117A1 Differentiation of htlv-i and htlv-ii using synthetic peptides
10/18/1995EP0677104A1 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use
10/18/1995EP0677101A1 Peptides representing epitopic sites for bacterial and viral meningitis causing agents and their cns carrier, antibodies thereto, and uses thereof
10/18/1995EP0676966A1 Antibodies directed against binding-associated epitopes
10/18/1995EP0676965A1 Compounds having reduced immunogenicity and a method of reducing the immunogenicity of compounds
10/18/1995EP0676964A1 Nitrosylation of protein sh groups and amino acid residues as a therapeutic modality
10/18/1995CN1110323A Novel polypeptides and DNAS encoding them
10/18/1995CN1110280A Targeted forms of methyltrithio antitumor agents
10/18/1995CN1110279A Method for extracting albumen from animal's blood by precipitating method
10/18/1995CN1110177A Materials and methods for immunocontraception
10/17/1995US5459251 And a polynucleotide comprising the same that is expressed or replicated in bacteria
10/17/1995US5459240 Genetic engineering of proteins
10/17/1995US5459235 Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils
10/17/1995US5459068 Polymorphonuclear leukocytes, measuring chloride secretion of intestinal epithelial cells, detecting presence of short circuit current
10/17/1995US5459061 Hybridomas producing monoclonal antibodies which specifically bind to continuous epitope on the human EGF receptor and compete with EGF for binding to the EGF receptor
10/17/1995US5459060 Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1)
10/17/1995US5459044 High affinity monoclonal antibodies to Bowman-Birk inhibitor and immunoassay methods
10/17/1995US5459043 Hybridoma CT43 producing a monoclonal antibody to a novel mucin epitope which correlates with the presence of colorectal cancer
10/17/1995US5459036 Extracellular signal-regulated kinase, sequences, and methods of production and use
10/17/1995US5458878 P. exotoxin fusio proteins have COOHG220101al alterations which increase cytotoxicity
10/17/1995US5458874 Method of increasing monocyte chemotaxis with CAP37 and monocyte chemotactic portions thereof
10/12/1995WO1995027075A1 Biological markers of benign prostate hyperplasia
10/12/1995WO1995027066A2 Dna encoding ubiquitin conjugating enzymes
10/12/1995WO1995027062A1 Agonist antibodies against the flk2/flt3 receptor and uses thereof
10/12/1995WO1995027061A1 Protein tyrosine kinase agonist antibodies
10/12/1995WO1995027059A1 Afamin: a human serum albumin-like protein
10/12/1995WO1995027057A1 GENE CODING FOR IgG-Fc-BINDING PROTEIN
10/12/1995WO1995027052A1 Human interleukin variants generated by alternative splicing
10/12/1995WO1995027045A1 The isolation and production of catalytic antibodies using phage technology
10/12/1995WO1995027042A1 Genetically modified cells for use in transplantation
10/12/1995WO1995026986A1 Monoclonal antibody to oncofetal protein for treating and detecting cancer
10/12/1995WO1995026977A1 High salt binding buffer for immunoglobulin purification with a synthetic affinity ligand
10/12/1995WO1995026746A1 Compositions and methods for stimulating megakaryocyte growth and differentiation
10/12/1995WO1995026743A1 Nadh oxidase as a target in diagnosis and therapy
10/12/1995WO1995026741A1 Cells with multiple altered epitopes on a surface antigen for use in transplantation
10/12/1995WO1995026740A1 Improved methods for transplantation using modified cells and t cell inhibitory agents
10/12/1995WO1995009232A3 Peptides representing epitopic sites for bacterial and viral meningitis causing agents and their cns carrier, antibodies thereto, and uses thereof
10/12/1995CA2187200A1 Nadh oxidase as a target in diagnosis and therapy
10/12/1995CA2186861A1 Biological markers of benign prostate hyperplasia
10/12/1995CA2186857A1 Monoclonal antibody to oncofetal protein for treating and detecting cancer
10/12/1995CA2186854A1 Human interleukin variants generated by alternative splicing
10/12/1995CA2186529A1 Cells with multiple altered epitopes on a surface antigen for use in transplantation
10/12/1995CA2186528A1 Genetically modified cells for use in transplantation
10/12/1995CA2186527A1 Improved methods for transplantation using modified cells and t cell inhibitory agents
10/12/1995CA2186516A1 Afamin: a human serum albumin-like protein
10/12/1995CA2186469A1 The isolation and production of catalytic antibodies using phage technology
10/12/1995CA2185211A1 Agonist antibodies against the flk2/flt3 receptor and uses thereof
10/12/1995CA2163619A1 High salt binding buffer for immunoglobulin purification with a synthetic affinity ligand
10/11/1995EP0676470A1 Stem cell factor
10/11/1995EP0676467A2 European vaccine strains of the porcine reproductive respiratory syndrome virus (PRRSV)
10/11/1995EP0676413A2 Interferon-alpha/beta binding protein, its preparation and use
10/11/1995EP0676052A1 Detection of cystic fibrosis or a cftr gene mutation
10/11/1995EP0675904A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus
10/11/1995EP0675903A1 Bone resorption assay
10/11/1995EP0675736A1 Improved synthesis of polymer bio-active conjugates
10/11/1995EP0675735A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof
10/11/1995EP0675734A1 ALLERGEN-SPECIFIC IgA MONOCLONAL ANTIBODIES AND RELATED PRODUCTS FOR ALLERGY TREATMENT
10/11/1995EP0675729A1 ACTIVATION OF p53 PROTEIN
10/11/1995EP0675728A1 Products and methods for improving keratinocyte adhesion to the dermis
10/11/1995EP0460167B1 Humanised antibodies
10/11/1995EP0397700B1 Sf-25 colon adenocarcinoma antigen, and antibodies which recognize this antigen
10/10/1995US5457182 An isolated, purified homogeneous polypeptide having a specific binding the immunosuppressant, but not cyclosporine
1 ... 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 ... 1494